NCT04371588

Brief Summary

Muscle relaxant is usually needed for surgery. However, the optimal depth of neuro-muscular blockade is still on debate. Deep neuro-muscular blockade may benefit the patients during surgery, but may increase the risk of residual blockade after surgery. Residual blockade has been reported to increase risk of morbidity. In this study, we tend to observe the postoperative outcomes in patients undergoing abdominal surgery under general anesthesia. And to compare the outcomes in patients received different depth of neuro-muscular blockade.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
999

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2018

Typical duration for all trials

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2018

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

April 27, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 1, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 12, 2021

Completed
Last Updated

September 2, 2022

Status Verified

August 1, 2022

Enrollment Period

3.4 years

First QC Date

April 27, 2020

Last Update Submit

August 31, 2022

Conditions

Keywords

muscle relaxantgeneral anesthesiaChinese patient

Outcome Measures

Primary Outcomes (2)

  • Visual Analogue Scale of pain at rest at 24 hours after surgery

    The intensity of pain is reported by the patient by provide a number between 0 and 10. 0 means no pain, and 10 means unbearable pain. Higher score means stronger pain.

    from end of surgery to 24 hours after surgery

  • Visual Analogue Scale of pain at cough at 24 hours after surgery

    The intensity of pain is reported by the patient by provide a number between 0 and 10. 0 means no pain, and 10 means unbearable pain. Higher score means stronger pain.

    from end of surgery to 24 hours after surgery

Secondary Outcomes (5)

  • Incidence of patients suffering pain at 24 hours after surgery

    from end of surgery to 24 hours after surgery

  • Time to flatus

    from end of surgery to flatus, on an average of 3 days

  • Time to extubation of the endotracheal tube

    from end of surgery to removal of the endotracheal tube, on an average of 15 minutes

  • Incidence of major postoperative complications

    from end of surgery to discharge from the hospital, on an average of 5 days

  • Satisfaction score of the Surgeon to the condition during surgery

    from start of surgery to end of surgery, on an average of 2.5 hours

Study Arms (2)

Deep neuro-muscular blockade

Other: No Response to Train of Four Stimulation

Moderate neuro-muscular blockade

Other: 1-2 Response to Train of Four Stimulation

Interventions

No response is observed during Train of Four stimulation monitoring during surgery

Deep neuro-muscular blockade

1 to 2 response is observed during Train of Four stimulation monitoring during surgery

Moderate neuro-muscular blockade

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for laparoscopic surgery are consecutively screened with inclusion and exclusion criteria.

You may qualify if:

  • Age ≥18 years old
  • Body mass \<18 kg/m2
  • American Society of Anesthesiologists status I-II
  • Patients scheduled for elective laparoscopic colorectal or urological surgery
  • Patients received general anesthesia and muscle relaxant
  • Patients with written informed consent.

You may not qualify if:

  • Second surgery during the same admission.
  • Outpatient surgery
  • Retroperitoneal laparoscopic surgery
  • Patients scheduled for mechanical ventilation after surgery
  • Patients scheduled for muscle relaxant other than rocuronium
  • Patients with pregnancy or planned for breeding
  • Patients who are involved in other studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

First hospital of Beijing University

Beijing, Beijing Municipality, China

Location

Xiehe Hospital of Fujian Medical University

Fuzhou, Fujian, China

Location

First Afiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450052, China

Location

Tongji Hospital of Tongji Medical School

Wuhan, Hubei, China

Location

Xiehe Hospital of Tongji Medical School

Wuhan, Hubei, China

Location

Ruijin Hospital

Shanghai, Shanghai Municipality, China

Location

Huaxi Hospital

Chengdu, Sichuan, China

Location

General hospital of Tianjin Medical University

Tianjin, Tianjin Municipality, China

Location

People's Hospital of Jiangsu

Nanjing, China

Location

Related Publications (2)

  • Madsen MV, Istre O, Staehr-Rye AK, Springborg HH, Rosenberg J, Lund J, Gatke MR. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: A randomised controlled trial. Eur J Anaesthesiol. 2016 May;33(5):341-7. doi: 10.1097/EJA.0000000000000360.

    PMID: 26479510BACKGROUND
  • Torensma B, Martini CH, Boon M, Olofsen E, In 't Veld B, Liem RS, Knook MT, Swank DJ, Dahan A. Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial. PLoS One. 2016 Dec 9;11(12):e0167907. doi: 10.1371/journal.pone.0167907. eCollection 2016.

    PMID: 27936214BACKGROUND

MeSH Terms

Conditions

Postoperative ComplicationsMuscle Hypotonia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 27, 2020

First Posted

May 1, 2020

Study Start

March 17, 2018

Primary Completion

August 12, 2021

Study Completion

August 12, 2021

Last Updated

September 2, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations